Synthon-based ligand discovery in virtual libraries of over 11 billion compounds

Nature ◽  
2021 ◽  
Author(s):  
Arman A. Sadybekov ◽  
Anastasiia V. Sadybekov ◽  
Yongfeng Liu ◽  
Christos Iliopoulos-Tsoutsouvas ◽  
Xi-Ping Huang ◽  
...  
2021 ◽  
Author(s):  
Lewis Martin

<p>There is renewed interest in docking campaigns for ligand-discovery since the advent of ultra-large scale virtual libraries. Using brute-force search, the scale of the libraries suggests highly parallelized compute should be used to avoid years-long computations. This paper reports a re-analysis of docking data from an ultra-large docking campaign at the D4 receptor and AmpC beta lactamase, and demonstrates large reductions in computation time to identify the top-ranked ligands. A search of ‘baseline’ featurizations shows that logistic regression on Morgan fingerprints with pharmacophoric atom invariants can match the reported performance on the same task using message-passing networks. With this approach, an ultra-large docking campaign could be performed in a matter of weeks using consumer-grade CPUs with <i>RDKit </i>and <i>scikit-learn</i>. All code and figures are available at <a href="https://github.com/ljmartin/dockop">https://github.com/ljmartin/dockop</a> </p><br>


2021 ◽  
Author(s):  
Lewis Martin

<p>There is renewed interest in docking campaigns for ligand-discovery since the advent of ultra-large scale virtual libraries. Using brute-force search, the scale of the libraries suggests highly parallelized compute should be used to avoid years-long computations. This paper reports a re-analysis of docking data from an ultra-large docking campaign at the D4 receptor and AmpC beta lactamase, and demonstrates large reductions in computation time to identify the top-ranked ligands. A search of ‘baseline’ featurizations shows that logistic regression on Morgan fingerprints with pharmacophoric atom invariants can match the reported performance on the same task using message-passing networks. With this approach, an ultra-large docking campaign could be performed in a matter of weeks using consumer-grade CPUs with <i>RDKit </i>and <i>scikit-learn</i>. All code and figures are available at <a href="https://github.com/ljmartin/dockop">https://github.com/ljmartin/dockop</a> </p><br>


2020 ◽  
Author(s):  
Silvia Acosta Gutiérrez ◽  
Igor Bodrenko ◽  
Matteo Ceccarelli

The lack of new drugs for Gram-negative pathogens is a global threat to modern medicine. The complexity of their cell envelope, with an additional outer membrane, hinders internal accumulation and thus, the access of molecules to targets. Our limited understanding of the molecular basis for compound influx and efflux from these pathogens is a major bottleneck for the discovery of effective antibacterial compounds. Here we analyse the correlation between the whole-cell compound accumulation of ~200 molecules and their predicted porin permeability coefficient (influx), using a recently developed scoring function. We found a strong linear relationship (75%) between the two, confirming porins key role in compound penetration. Further, the remarkable prediction ability of the scoring function demonstrates its potentiality to guide the optimization of hits to leads as well as the possibility of screening ultra-large virtual libraries. Eventually, the analysis of false positives, molecules with high-predicted influx but low accumulation, provides new hints on the molecular properties behind efflux.<br>


2021 ◽  
Vol 14 (677) ◽  
pp. eaav0320
Author(s):  
Tao Che ◽  
Hemlata Dwivedi-Agnihotri ◽  
Arun K. Shukla ◽  
Bryan L. Roth

The opioid crisis represents a major worldwide public health crisis that has accelerated the search for safer and more effective opioids. Over the past few years, the identification of biased opioid ligands capable of eliciting selective functional responses has provided an alternative avenue to develop novel therapeutics without the side effects of current opioid medications. However, whether biased agonism or other pharmacological properties, such as partial agonism (or low efficacy), account for the therapeutic benefits remains questionable. Here, we provide a summary of the current status of biased opioid ligands that target the μ- and κ-opioid receptors and highlight advances in preclinical and clinical trials of some of these ligands. We also discuss an example of structure-based biased ligand discovery at the μ-opioid receptor, an approach that could revolutionize drug discovery at opioid and other receptors. Last, we briefly discuss caveats and future directions for this important area of research.


2021 ◽  
Vol 17 (4) ◽  
pp. 501-501 ◽  
Author(s):  
Tony Ngo ◽  
Andrey V. Ilatovskiy ◽  
Alastair G. Stewart ◽  
James L. J. Coleman ◽  
Fiona M. McRobb ◽  
...  

2021 ◽  
Author(s):  
Wenchao Lu ◽  
Milka Kostic ◽  
Tinghu Zhang ◽  
Jianwei Che ◽  
Matthew P. Patricelli ◽  
...  
Keyword(s):  

Correction for ‘Fragment-based covalent ligand discovery’ by Wenchao Lu et al., RSC Chem. Biol., 2021, DOI: 10.1039/d0cb00222d.


Sign in / Sign up

Export Citation Format

Share Document